PDK4 and metastatic neoplasm: In addition, PDK4 is an independent predictor of BCR compared to ISUP grading and clinical staging, as well as pathological staging and pre‐surgical PSA levels in primary and metastatic tumors, identifying PDK4 as a promising prognostic marker in PCa.